Condition: Ulcerative Colitis · Obesity or Overweight · Sponsor: Eli Lilly and Company
The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disappearance of UC symptoms, and loss of at least one-tenth of the overall body weight. Participation in this study will last up to 61 weeks, including 52 weeks of treatment.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| Digestive Health Specialists | Dothan, Alabama, United States | Recruiting |
| Smart Cures Clinical Research | Anaheim, California, United States | Recruiting |
| Cedars-Sinai Medical Center | Beverly Hills, California, United States | Not Yet Recruiting |
| United Medical Doctors - Los Alamitos | Los Alamitos, California, United States | Recruiting |
| California Medical Research Associates | Northridge, California, United States | Recruiting |
| Research Associates of South Florida - Miami - Southwest 8th Street | Miami, Florida, United States | Recruiting |
| Gastro Health Research - Miami | Miami, Florida, United States | Recruiting |
| Orlando Health | Orlando, Florida, United States | Recruiting |
| Digestive and Liver Center of Florida | Orlando, Florida, United States | Recruiting |
| Gastro Health Research - Pensacola | Pensacola, Florida, United States | Recruiting |
| Precision Clinical Research | Sunrise, Florida, United States | Recruiting |
| Grand Teton Research Group | Idaho Falls, Idaho, United States | Recruiting |
+ 177 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06937086